journal article·2025-07-25Open access

Optimization of Impedance-Based Real-Time Assay in xCELLigence RTCA SP16 Device for the Analysis of Fully Differentiated Caco-2 Cells

Nadia Khan, Magdalena Kurnik-Łucka, Maja Kudrycka, Krzysztof Gil, Gniewomir Latacz

Applied Sciences· Volume 15· Issue 15

Abstract

Impedance-based cellular assays allow determination of biological functions of cell populations in real-time by measuring electrical impedance. As compared to end-point assays, such as trans-epithelial electrical resistance assays, for example, they enable fast, non-invasive, and easy detection of cell kinetics—their growth, attachment, and interaction can be monitored over time. In our experiment, Caco-2 cells were cultured on E-plates 16. Next, fully differentiated cells were treated with either TNF-α or 3,4-dihydroxy-L-phenylalanine (L-DOPA). We aimed to verify the possibility of real-time testing of the viability, monolayer formation, and integrity (i.e., the presence of a functional and polarized monolayer) of Caco-2 cells by the xCELLigence real-time cell analyzer (RTCA) S16 system (Agilent Technologies).
Source: crossref · Quality: baseline

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Microfluidic and Bio-sensing Technologies · Cell Image Analysis Techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Doctoral School of Medical and Health Sciences, Jagiellonian University Medical College, św. Łazarza 16, 31-530 Cracow, Poland

Department of Pathophysiology, Faculty of Medicine, Jagiellonian University Medical College, Czysta 18, 31-121 Cracow, Poland

Center for the Development of Therapies for Civilization and Age-Related Diseases, Jagiellonian University Medical College, Medyczna 9, 31-066 Cracow, Poland

Faculty of Pharmacy, Department of Technology and Biotechnology of Drugs, Jagiellonian University Medical College, Medyczna 9, 31-008 Cracow, Poland

Funding

Priority Research Area qLife under the program “Excellence Initiative—Research University” at the Jagiellonian University in Krakow · Jagiellonian University Medical College

References (31)

Show source-provided references
1. Fluorescence microscopy-an outline of hardware, biological handling, and fluorophore considerations
2. Impact of new technologies for cellular screening along the drug value chain10.1016/j.drudis.2010.02.010 ↗
3. Hamidi, H., Lilja, J., and Ivaska, J. (2017). Using xCELLigence RTCA instrument to measure cell adhesion. Bio-Protocol, 7.10.21769/BioProtoc.2646 ↗
4. Label-free technology and patient cells: From early drug development to precision medicine10.1016/j.drudis.2017.07.015 ↗
5. Impedance-based cellular assay technologies: Recent advances, future promise10.1016/j.coph.2007.08.004 ↗
6. Junctional complexes in various epithelia10.1083/jcb.17.2.375 ↗
7. Three types of gap junctions interconnecting intestinal epithelial cells visualized by freeze-etching10.1073/pnas.69.5.1318 ↗
8. Tight junctions and the modulation of barrier function in disease10.1007/s00418-008-0424-9 ↗
9. Regulation of tight junctions and loss of barrier function in pathophysiology10.1016/j.biocel.2003.08.007 ↗
10. Occludin: A novel integral membrane protein localizing at tight junctions10.1083/jcb.123.6.1777 ↗
11. Lopez-Escalera, S., and Wellejus, A. (2022). Evaluation of Caco-2 and human intestinal epithelial cells as in vitro models of colonic and small intestinal integrity. Biochem. Biophys. Rep., 31.10.1016/j.bbrep.2022.101314 ↗
12. Lea, T. (2015). Caco-2 Cell Line. The Impact of Food Bioactives on Health: In Vitro and Ex Vivo Models, Springer.10.1007/978-3-319-16104-4_10 ↗
13. Impedance-based cell monitoring: Barrier properties and beyond10.1186/2045-8118-10-5 ↗
14. Application of xcelligence RTCA biosensor technology for revealing the profile and window of drug responsiveness in real time10.3390/bios5020199 ↗
15. Morgan, K., Gamal, W., Samuel, K., Morley, S.D., Hayes, P.C., Bagnaninchi, P., and Plevris, J.N. (2020). Application of impedance-based techniques in hepatology research. J. Clin. Med., 9.10.3390/jcm9010050 ↗
16. A dynamic real-time method for monitoring epithelial barrier function in vitro10.1016/j.ab.2012.03.010 ↗
17. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability10.1016/S0016-5085(89)80072-1 ↗
18. Enterocyte-like differentiation and polarization of the human-colon carcinoma cell-line Caco-2 in culture
19. A protocol for differentiation of human intestinal Caco-2 cells in asymmetric serum-containing medium10.1016/j.tiv.2012.01.008 ↗
20. Tumor necrosis factor alpha increases epithelial barrier permeability by disrupting tight junctions in Caco-2 cells10.1590/S0100-879X2010007500020 ↗
21. Occludin protein family: Oxidative stress and reducing conditions10.1089/ars.2010.3542 ↗
22. Balas, M., Dumitrache, F., Badea, M.A., Fleaca, C., Badoi, A., Tanasa, E., and Dinischiotu, A. (2018). Coating dependent in vitro biocompatibility of new Fe-Si Nanoparticles. Nanomaterials, 8.10.3390/nano8070495 ↗
23. Reuse of E-plate cell sensor arrays in the xCELLigence Real-Time Cell Analyzer10.2144/000114450 ↗
24. Tight Junction in the Intestinal Epithelium: Its Association with Diseases and Regulation by Phytochemicals
25. TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation10.1152/ajpgi.00173.2003 ↗
26. Bile salts and proinflammatory cytokines inhibit MCT1-mediated cellular uptake of butyrate and interfere with its antiproliferative properties10.1016/j.yexcr.2023.113670 ↗
27. Toxic effects of L-DOPA on mesencephalic cell cultures: Protection with antioxidants10.1016/0006-8993(95)00341-M ↗
28. Uptake and intracellular fate of L-DOPA in a human intestinal epithelial cell line: Caco-210.1152/ajpcell.1998.275.1.C104 ↗
29. Mitochondrial dysfunction mediated by quinone oxidation products of dopamine: Implications in dopamine cytotoxicity and pathogenesis of Parkinson’s disease10.1016/j.bbadis.2011.02.013 ↗
30. Caco-2 cells express a combination of colonocyte and enterocyte phenotypes10.1002/(SICI)1097-4652(199803)174:3<362::AID-JCP10>3.0.CO;2-B ↗
31. Analysis of drug transporter expression in human intestinal Caco-2 cells by real-time PCR10.1111/j.1472-8206.2007.00550.x ↗